Yushan Yang

Papers

Total Citations

H-Index

About

Yushan Yang is a pioneering urological surgeon whose research focuses on advancing minimally invasive surgical techniques, particularly in robotic-assisted partial nephrectomy for kidney cancer. Yang’s most notable contribution is leading the ROPARN study, a landmark randomised controlled feasibility trial that directly compared retroperitoneal versus transperitoneal robot-assisted partial nephrectomy. This work, published in 2025 and already garnering 9 citations, demonstrated that the retroperitoneal approach offers significant time advantages and reduced peri-operative morbidity while maintaining equivalent oncological efficacy to the traditional transperitoneal method. By rigorously testing these surgical pathways, Yang has provided crucial evidence that could reshape standard practice in nephron-sparing surgery, potentially shortening recovery times and improving outcomes for kidney cancer patients worldwide. The study’s design as a feasibility trial also lays essential groundwork for larger multicentre randomised controlled trials. Yang’s research sits at the intersection of surgical innovation and rigorous clinical evidence, addressing a key question in robotic urology: how to optimise surgical access to minimise patient harm without compromising cancer control. This work establishes Yang as a rising leader in evidence-based surgical oncology, with clear implications for future clinical guidelines and training protocols in robotic partial nephrectomy.